Willingdon Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
$4.77M Buy
158,486
+9,084
+6% +$273K 1.2% 30
2019
Q4
$4.32M Buy
149,402
+7,996
+6% +$231K 0.89% 37
2019
Q3
$3.66M Buy
141,406
+4,184
+3% +$108K 0.8% 41
2019
Q2
$3.5M Buy
137,222
+7,204
+6% +$184K 0.81% 41
2019
Q1
$3.4M Buy
130,018
+2,564
+2% +$67.1K 0.83% 45
2018
Q4
$2.94M Buy
127,454
+11,552
+10% +$266K 0.85% 42
2018
Q3
$2.73M Buy
115,902
+2,668
+2% +$62.9K 0.75% 58
2018
Q2
$2.61M Buy
113,234
+5,186
+5% +$120K 0.8% 56
2018
Q1
$2.66M Buy
108,048
+11,526
+12% +$284K 0.84% 48
2017
Q4
$2.59M Buy
96,522
+2,618
+3% +$70.2K 0.85% 51
2017
Q3
$2.26M Buy
93,904
+3,272
+4% +$78.8K 0.82% 52
2017
Q2
$1.94M Buy
90,632
+2,650
+3% +$56.8K 0.77% 63
2017
Q1
$1.51M Buy
87,982
+4,442
+5% +$76.1K 0.61% 67
2016
Q4
$1.5M Buy
83,540
+4,714
+6% +$84.5K 0.71% 62
2016
Q3
$1.64M Buy
78,826
+33,110
+72% +$688K 0.83% 54
2016
Q2
$1.23M Buy
45,716
+964
+2% +$25.9K 0.63% 71
2016
Q1
$1.21M Sell
44,752
-45,148
-50% -$1.22M 0.74% 64
2015
Q4
$2.61M Buy
89,900
+4,724
+6% +$137K 2.39% 8
2015
Q3
$2.31M Sell
85,176
-720
-0.8% -$19.5K 2.75% 5
2015
Q2
$2.35M Sell
85,896
-10,622
-11% -$291K 2.25% 6
2015
Q1
$2.58M Sell
96,518
-27,216
-22% -$727K 2.14% 10
2014
Q4
$2.62M Buy
123,734
+96
+0.1% +$2.03K 1.65% 19
2014
Q3
$2.94M Buy
123,638
+2,884
+2% +$68.7K 1.94% 15
2014
Q2
$2.79M Sell
120,754
-45,716
-27% -$1.06M 1.93% 14
2014
Q1
$3.8M Sell
166,470
-1,850
-1% -$42.2K 2.67% 3
2013
Q4
$3.11M Buy
+168,320
New +$3.11M 2.44% 9